cerezyme 400
sanofi-aventis south africa - imiglucerase - lyophilised powder - each 10 ml liquid contains; imiglucerase 400,0 units
vpriv 40 u powder for solution for infusion
shire pharmaceutical ireland ltd, ireland - velaglucerase alfa - powder for solution for infusion - 400 u
vpriv 40 u powder for solution for infusion
shire human genetics therapies - velaglucerase alfa - powder for solution for infusion - 400 u
vpriv 40 u powder for solution for infusion
takeda pharmaceuticals international ag, ireland - velaglucerase alfa - powder for solution for infusion - 400 u
vpriv injection 400 u (ビプリブ点滴静注用400単位)
takeda pharmaceutical company limited. - velaglucerase alfa (genetical recombination) - injection
cerezyme 200 units
sanofi - aventis israel ltd - imiglucerase 200 u/vial - powder for solution for infusion - imiglucerase - for the long term enzyme replacement therapy for patients with a confirmed diagnosis of type 1 gaucher disease that results in one or more of the following conditions: - anemia , - thrombocytopenia , - bone disease , - hepatomegaly or splenomegaly.
cerezyme 400 u power for intravenous infusion
n/a; importer: sanofi-aventis philippines, inc.; distributor: sanofi-aventis philippines, inc. - imiglucerase - power for intravenous infusion - 400 u
cerezyme 200unit powder for solution for infusion vials
genzyme therapeutics ltd - imiglucerase - powder for solution for infusion - 200unit
cerezyme 400 u powder for concentrate for solution for infusion
genzyme europe b.v., netherlands - imiglucerase - powder for concentrate for solution for infusion - 400 u
cerezyme 400 u/vial
شركة ألفه للأدوية - ulfa pharma co. - imiglucerase 400 u/vial - 400 u/vial